| 1 |
Kim M, Lee NK, Wang CJ, Lim J, Byun MJ, Kim TH, Park W, Park DH, Kim SN, Park CG. Reprogramming the tumor microenvironment with biotechnology. Biomater Res 2023;27:5. [PMID: 36721212 DOI: 10.1186/s40824-023-00343-4] [Reference Citation Analysis]
|
| 2 |
Guan X, Li Z, Geng X, Lei Z, Karakoti A, Wu T, Kumar P, Yi J, Vinu A. Emerging Trends of Carbon-Based Quantum Dots: Nanoarchitectonics and Applications. Small 2023;:e2207181. [PMID: 36693792 DOI: 10.1002/smll.202207181] [Reference Citation Analysis]
|
| 3 |
Zeković M, Bumbaširević U, Živković M, Pejčić T. Alteration of Lipid Metabolism in Prostate Cancer: Multifaceted Oncologic Implications. Int J Mol Sci 2023;24. [PMID: 36674910 DOI: 10.3390/ijms24021391] [Reference Citation Analysis]
|
| 4 |
Pal S, Sharma A, Mathew SP, Jaganathan BG. Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics. Front Immunol 2022;13:955476. [PMID: 36618350 DOI: 10.3389/fimmu.2022.955476] [Reference Citation Analysis]
|
| 5 |
Morais CM, Cardoso AM, Araújo ARD, Reis A, Domingues P, Domingues MRM, de Lima MCP, Jurado AS. Stearoyl CoA Desaturase-1 Silencing in Glioblastoma Cells: Phospholipid Remodeling and Cytotoxicity Enhanced upon Autophagy Inhibition. IJMS 2022;23:13014. [DOI: 10.3390/ijms232113014] [Reference Citation Analysis]
|
| 6 |
Estrada-pérez AR, Bakalara N, García-vázquez JB, Rosales-hernández MC, Fernández-pomares C, Correa-basurto J. LC–MS Based Lipidomics Depict Phosphatidylethanolamine as Biomarkers of TNBC MDA-MB-231 over nTNBC MCF-7 Cells. IJMS 2022;23:12074. [DOI: 10.3390/ijms232012074] [Reference Citation Analysis]
|
| 7 |
Herianto S, Subramani B, Chen BR, Chen CS. Recent advances in liposome development for studying protein-lipid interactions. Crit Rev Biotechnol 2022;:1-14. [PMID: 36170980 DOI: 10.1080/07388551.2022.2111294] [Reference Citation Analysis]
|
| 8 |
Li Y, Zhao J, Chen R, Chen S, Xu Y, Cai W. Integration of clinical and transcriptomics reveals programming of the lipid metabolism in gastric cancer. BMC Cancer 2022;22:955. [PMID: 36064336 DOI: 10.1186/s12885-022-10017-4] [Reference Citation Analysis]
|
| 9 |
Rupp T, Debasly S, Genest L, Froget G, Castagné V. Therapeutic Potential of Fingolimod and Dimethyl Fumarate in Non-Small Cell Lung Cancer Preclinical Models. Int J Mol Sci 2022;23:8192. [PMID: 35897763 DOI: 10.3390/ijms23158192] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Pereira M, Matuszewska K, Glogova A, Petrik J. Mutant p53, the Mevalonate Pathway and the Tumor Microenvironment Regulate Tumor Response to Statin Therapy. Cancers 2022;14:3500. [DOI: 10.3390/cancers14143500] [Reference Citation Analysis]
|
| 11 |
Nyarumenteng Adhipurnawan Winarno G. Fatty Acid Metabolism as a Tumor Marker. Fatty Acids - Recent Advances [Working Title] 2022. [DOI: 10.5772/intechopen.106072] [Reference Citation Analysis]
|
| 12 |
Gizzi G, Cataldi S, Mazzeschi C, Delvecchio E, Ceccarini MR, Codini M, Albi E. Hypercholesterolemia in Cancer and in Anorexia Nervosa: A Hypothesis for a Crosstalk. IJMS 2022;23:7466. [DOI: 10.3390/ijms23137466] [Reference Citation Analysis]
|
| 13 |
Crocco M, Verrico A, Milanaccio C, Piccolo G, De Marco P, Gaggero G, Iurilli V, Di Profio S, Malerba F, Panciroli M, Giordano P, Calevo MG, Casalini E, Di Iorgi N, Garrè ML. Dyslipidemia in Children Treated with a BRAF Inhibitor for Low-Grade Gliomas: A New Side Effect? Cancers (Basel) 2022;14:2693. [PMID: 35681673 DOI: 10.3390/cancers14112693] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 14 |
Tu B, Gao Y, Sun F, Shi M, Huang Y. Lipid Metabolism Regulation Based on Nanotechnology for Enhancement of Tumor Immunity. Front Pharmacol 2022;13:840440. [PMID: 35392570 DOI: 10.3389/fphar.2022.840440] [Reference Citation Analysis]
|
| 15 |
Tőkés AM, Vári-kakas S, Kulka J, Törőcsik B. Tumor Glucose and Fatty Acid Metabolism in the Context of Anthracycline and Taxane-Based (Neo)Adjuvant Chemotherapy in Breast Carcinomas. Front Oncol 2022;12:850401. [DOI: 10.3389/fonc.2022.850401] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 16 |
Sayers NS, Anujan P, Yu HN, Palmer SS, Nautiyal J, Franks S, Hanyaloglu AC. Follicle-Stimulating Hormone Induces Lipid Droplets via Gαi/o and β-Arrestin in an Endometrial Cancer Cell Line. Front Endocrinol 2022;12:798866. [DOI: 10.3389/fendo.2021.798866] [Reference Citation Analysis]
|
| 17 |
Parkinson EK, Adamski J, Zahn G, Gaumann A, Flores-Borja F, Ziegler C, Mycielska ME. Extracellular citrate and metabolic adaptations of cancer cells. Cancer Metastasis Rev 2021. [PMID: 34932167 DOI: 10.1007/s10555-021-10007-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 18 |
Cai W, Bao W, Chen S, Yang Y, Li Y. Metabolic syndrome related gene signature predicts the prognosis of patients with pancreatic ductal carcinoma. A novel link between metabolic dysregulation and pancreatic ductal carcinoma. Cancer Cell Int 2021;21:698. [PMID: 34930261 DOI: 10.1186/s12935-021-02378-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 19 |
De Lerma Barbaro A, Palano MT, Cucchiara M, Gallazzi M, Mortara L, Bruno A. Metabolic Rewiring in the Tumor Microenvironment to Support Immunotherapy: A Focus on Neutrophils, Polymorphonuclear Myeloid-Derived Suppressor Cells and Natural Killer Cells. Vaccines (Basel) 2021;9:1178. [PMID: 34696286 DOI: 10.3390/vaccines9101178] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 20 |
Lee KC, Wu KL, Yen CK, Chen CN, Chang SF, Huang WS. 6-Shogaol Antagonizes the Adipocyte-Conditioned Medium-Initiated 5-Fluorouracil Resistance in Human Colorectal Cancer Cells through Controlling the SREBP-1 Level. Life (Basel) 2021;11:1067. [PMID: 34685438 DOI: 10.3390/life11101067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 21 |
Chen H, Han T, Zhao Y, Feng L. Identification of solute-carrier family 27A molecules (SCL27As) as a potential biomarker of ovarian cancer based on bioinformatics and experiments. Ann Transl Med 2021;9:1237. [PMID: 34532374 DOI: 10.21037/atm-21-3026] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 22 |
Derveaux E, Thomeer M, Mesotten L, Reekmans G, Adriaensens P. Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor. Metabolites 2021;11:537. [PMID: 34436478 DOI: 10.3390/metabo11080537] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 23 |
Graber M, Barta H, Wood R, Pappula A, Vo M, Petreaca RC, Escorcia W. Comprehensive Genetic Analysis of DGAT2 Mutations and Gene Expression Patterns in Human Cancers. Biology (Basel) 2021;10:714. [PMID: 34439946 DOI: 10.3390/biology10080714] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 24 |
Talukdar S, Emdad L, Gogna R, Das SK, Fisher PB. Metabolic control of cancer progression as novel targets for therapy. Adv Cancer Res 2021;152:103-77. [PMID: 34353436 DOI: 10.1016/bs.acr.2021.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 25 |
Wu X, Yu Y, Huang T. Synthesis and biological evaluation of 4-phenoxy-phenyl isoxazoles as novel acetyl-CoA carboxylase inhibitors. J Enzyme Inhib Med Chem 2021;36:1236-47. [PMID: 34100310 DOI: 10.1080/14756366.2021.1936514] [Reference Citation Analysis]
|
| 26 |
Balgoma D, Kullenberg F, Calitz C, Kopsida M, Heindryckx F, Lennernäs H, Hedeland M. Anthracyclins Increase PUFAs: Potential Implications in ER Stress and Cell Death. Cells 2021;10:1163. [PMID: 34064765 DOI: 10.3390/cells10051163] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
| 27 |
Monferrer E, Vieco-Martí I, López-Carrasco A, Fariñas F, Abanades S, de la Cruz-Merino L, Noguera R, Álvaro Naranjo T. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction. Metabolites 2021;11:264. [PMID: 33922558 DOI: 10.3390/metabo11050264] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 28 |
Balgoma D, Kullenberg F, Calitz C, Kopsida M, Heindryckx F, Lennernäs H, Hedeland M. Anthracyclins increase free PUFAs and etherPEs with PUFAs as potential hallmarks of lipid peroxidation and ferroptosis.. [DOI: 10.1101/2021.02.16.431377] [Reference Citation Analysis]
|
| 29 |
Olkkonen VM. The emerging roles of OSBP-related proteins in cancer: Impacts through phosphoinositide metabolism and protein-protein interactions. Biochem Pharmacol 2021;:114455. [PMID: 33556339 DOI: 10.1016/j.bcp.2021.114455] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 30 |
Bensen RC, Gunay G, Finneran MC, Jhingan I, Acar H, Burgett AWG. Small Molecule Targeting of Oxysterol-Binding Protein (OSBP)-Related Protein 4 and OSBP Inhibits Ovarian Cancer Cell Proliferation in Monolayer and Spheroid Cell Models. ACS Pharmacol Transl Sci 2021;4:744-56. [PMID: 33860198 DOI: 10.1021/acsptsci.0c00207] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
|
